ArticleAnesthesiology2026
Ropivacaine-based Regional Anesthesia Exerts Muscle-protective Effects Despite Elevated Compartment Pressure in a Porcine Model of Acute Compartment Syndrome.
Article in Anesthesiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute compartment syndrome (ACS) is a devastating sequela of orthopedic trauma characterized by elevated compartment pressure that precipitates tissue ischemia. The role of regional anesthesia in modulating these pathophysiological events remains controversial. This study investigated the impact of regional anesthesia via ropivacaine 0.2% (RPVC) on compartment pressure, systemic hemodynamics, biochemical markers, and tissue integrity in a porcine model of ACS.
methodsTwenty male pigs underwent ACS induction in the tibialis anterior compartment by targeted inflation of an angioplasty catheter and were randomized to receive either RPVC or placebo via a regional catheter. Continuous compartment pressure and mean arterial pressure were recorded. Plasma samples and interstitial fluid were collected at predefined time points (T1, T3, T6, T8, and T10) to quantify creatine kinase, lactate, lactate dehydrogenase, and glucose. Histopathologic evaluation was performed at the end of the experiment (T10).
resultsAt T10, compartment pressure was significantly elevated in the RPVC group (57.0 mmHg [49.0 to 59.0]) compared to placebo (41.5 mmHg [38.2 to 47.2]; P = 0.022), whereas mean arterial pressure remained comparable (RPVC: 63.0 mmHg [58.0 to 65.0] vs . placebo: 59.0 mmHg [56.2 to 61.8]; P = 0.13). Plasma biomarkers did not differ significantly ( e.g. , plasma creatinine kinase: RPVC 1940 U/l [868 to 3,334] vs . placebo 1,171 U/l [1,020 to 1,467]; P = 0.24). In contrast, interstitial analysis demonstrated a marked reduction in tissue injury markers in the RPVC group, with interstitial fluid lactate dehydrogenase significantly lower [24,475 U/l (19,500 to 28,213) vs . 113,800 U/l (91,000 to 116,600); P = 0.017] and interstitial fluid glucose substantially decreased (19.5 mg/dl [11.5 to 27.5] vs . 51.0 mg/dl [43.0 to 103.0]; P = 0.0043). RPVC-treated tissue exhibited attenuated degeneration and reduced necrosis in a blinded histopathologic scoring.
conclusionsDespite a higher compartment pressure, RPVC-based regional anesthesia yielded an improved regional metabolic profile and mitigated tissue injury in ACS. These findings suggest a protective effect in the observed timeframe that merits further clinical exploration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.